baber/WOPTO huggingface dataset:
Patent JP-2000506629-A (JP)
IPC: G02F1/15
Filed: 1997-03-13
Abstract: PCT No. PCT/CH97/00104 Sec. 371 Date Oct. 13, 1998 Sec. 102(e) Date Oct. 13, 1998 PCT Filed Mar. 13, 1997 PCT Pub. No. WO97/35227 PCT Pub. Date Sep. 25, 1997Electrochromic and photoelectrochromic devices using nanocrystalline semiconductor electrodes with a high specific surface area and surface-absorbed electrochromic molecules are disclosed.
Patent JP-2001511146-A (JP)
Title: 殺菌・殺カビ剤としてのピリジン環上にカルボン酸誘導基を有する２−メトキシイミノ−２−（ピリジニルオキシメチル）フェニルアセトアミド
IPC: C07D213/83
Filed: 1998-01-29
Abstract: (57)【要約】
本発明はピリジン環上にカルボン酸置換基を有する新規な２−メトキシイミノ−２−（ピリジニルオキシメチル）フェニルアセトアミド化合物、殺菌・殺カビ性化合物としてのその使用ならびに少なくとも１種の２−メトキシイミノ−２−（ピリジニルオキシメチル）フェニルアセトアミド化合物を活性成分として含む殺菌・殺カビ性組成物におけるその使用を提供する。
Patent JP-2001511042-A (JP)
IPC: A61K38/00
Filed: 1998-02-05
Abstract: The present invention provides the use of a matrix-free composition lacking a scaffolding structure comprising an osteogenic protein dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces for the preparation of pharmaceutical compositions for filling a defect locus, for repairing chondral or osteochondral defects or for accelerating cartilage formation at a defect locus.
Patent JP-2001506030-A (JP)
Title: 適応オブジェクト指向最適化ソフトウエアシステム
IPC: G05B13/04
Filed: 1998-02-20
Abstract: (57)【要約】
本発明は、ゴールシーキングインテリジェントソフトウェアオブジェクトを備えている適応最適化ソフトウェアシステムを利用するプロセス制御最適化システムに関する；ゴールシーキングインテリジェントソフトウェアオブジェクトは、エキスパートシステムオブジェクト、適応モデルオブジェクト、オプティマイザオブジェクト、プレディクタオブジェクト、センサオブジェクト、及び通信トランスレーションオブジェクトを含む内部ソフトウェアオブジェクトを更に備えている。ゴールシーキングインテリジェントソフトウェアオブジェクトは、階層関係に配置することができ、それによって各インテリジェントソフトウェアオブジェクトのゴールシーキング挙動は、階層構造のより高いゴールシーキングインテリジェントソフトウェアオブジェクトによって変更することができる。また、ゴールシーキングインテリジェントソフトウェアオブジェクトは、マテリアル又はデータの制御プロセスフローに表象的に対応する関係に配置することができる。
Patent JP-2000511572-A (JP)
IPC: C08K5/17
Filed: 1997-05-28
Abstract: PCT No. PCT/EP97/02796 Sec. 371 Date Nov. 25, 1998 Sec. 102(e) Date Nov. 25, 1998 PCT Filed May 28, 1997 PCT Pub. No. WO97/45461 PCT Pub. Date Dec. 4, 1997Thermally curable mixtures of hydroxyalkylated polyamines and polycarboxylic acids are formaldehyde-free and particularly useful as binders for shaped articles.
Patent JP-H11509718-A (JP)
Title: 符号化通信システムにおける再送信データの解読
IPC: H04L9/22
Filed: 1997-04-23
Abstract: (57)【要約】
メッセージの再送信部分を解読する方法は、暗号同期および複数の暗号化ブロックによって構成されるメッセージを受信する（２０１）ことを含む。複数の暗号化ブロックのうち第１ブロックがエラーで受信されるまで、第１キーストリームは、暗号同期および複数の暗号化ブロックの少なくとも一つのブロックから生成され（２０５）、複数の暗号化ブロックの第１ブロックがエラーで受信される前にエラーなしで受信された複数の暗号化ブロックは、第１キーストリームを利用して解読される（２０７）。プライミング・ブロックはメッセージから決定される（２１１）。複数の暗号化ブロックの第１ブロックがエラーで受信されると、第１ブロックの再送信を要求する第２メッセージが送信される（２１９）。第１ブロックの再送信をエラーなし受信すると、プライミング・ブロックおよび第１ブロックの再送信から第２キーストリームが生成され（２２３）、第１ブロックの再送信は第２キーストリームを利用して解読される（２２５）。
Patent JP-2001527625-A (JP)
IPC: F16B7/06
Filed: 1998-03-25
Abstract: A rod anchor is threadedly connected to a tension rod. The rod anchor includes an anchor head having a threaded first bore hole formed therein, and a sealing nut attached to the anchor head in sealing relationship therewith. The sealing member forms a second bore hole axially aligned with the first bore hole, whereby a threaded end of the tension rod extends through the second bore hole and into threaded engagement with the first bore hole. The sealing nut includes sealing material forming a seal between the sealing nut and the tension rod.
Patent JP-2001523433-A (JP)
Title: 移動無線端末
IPC: H04R3/00
Filed: 1999-03-04
Abstract: (57)【要約】
本発明は、受話口、拡声器、およびベルの機能を提供するオーディオ変換器（５）を含む無線通信端末に関し、オーディオ変換器の１つの出力（６）が端末の前面に向けて配置され、この端末は、変換器に結合された、前面に対してほぼ垂直な１つの主方向（Ｄ）に沿って変換器から伝送された音波のレベルを調節する手段（Ｒ１、９’、１１、１２）さらに含み、この調節は、ユーザの位置に対して端末がどのような相対位置にあっても実行される。
Patent JP-2001521429-A (JP)
IPC: C03C8/22
Filed: 1998-04-15
Abstract: A porous composite suitable for filling a recess or a through-passing hole in an implant. The composite includes particles A prepared from a bioactive material and particles B prepared from a non-bioactive material or weakly bioactive material, which is sintratable with the bioactive material, such that particles A and particles B have been sintered together to a porous composite. Particles A and particles B are essentially homogeneous in size. Also disclosed is an implant which contains a core and the composite.
Patent JP-2002500697-A (JP)
Title: オレフィン重合用の予備重合された触媒成分
IPC: C08F4/657
Filed: 1999-03-18
Abstract: (57)【要約】
この発明は、Ti、Mg、ハロゲンおよび電子供与性化合物からなり、通常の重合条件下で25℃のキシレン中で90％より高い不溶性を有するプロピレンホモポリマーを生じうる、エチレンプレポリマーの量が該固形触媒成分のｇあたり100gまでの量であるような程度にエチレンと予備重合された、固形触媒成分からなることを特徴とする、オレフィンＣＨ 2 ＝ＣＨＲ［式中、Ｒは水素またはＣ１〜Ｃ１２アルキル基である］の（共）重合用の予備重合された新規触媒成分を提供する。これらそのような触媒成分は、高い触媒活性、高いアイソタクチック指数を得ることができ、老化に影響されない。
Patent JP-2000514663-A (JP)
Title: 大豆栽培のための強化接種材料
IPC: A01N63/20
Filed: 1998-04-02
Abstract: (57)【要約】
特に大豆の成長を助けるために根粒菌株が設計される。抗生物質、トリフォリトキシンを作製するための高いコピー数のプラスミドを記述する。かかるプラスミドは好ましくは、大豆の根に根粒形成することができるシノリゾビウム種をホストとする。トリフォリトキシン産生の表現型は、競合菌株を抑制することにより接種菌株に競合的優位性を与える。大豆の成長を促進するために、同じシノリゾビウム菌株あるいは同じ接種材料中に組み込まれた付随する根粒菌のトリフォリトキシン耐性菌株のいずれかにおいて、別個の水素吸収能力も接種材料中に包含する。
Patent JP-2001524225-A (JP)
Title: 輝度向上物品
IPC: G02B5/04
Filed: 1998-05-06
Abstract: (57)【要約】
輝度向上物品は、(ａ)透明で可撓性のある基体と、(ｂ)弦幅と、断面ピッチ幅と、曲率半径とを特徴とし、弦幅は断面ピッチ幅の約２０〜４０％に等しく、曲率半径は断面ピッチ幅の約２０〜５０％に等しい、鈍いまたは丸いピークを備えたプリズムの配列群を含む第１の主要面と、(ｃ)複数の光散乱性突起物を特徴とする第２の主要面と、を含む。第１の面が実質的に平坦な形態を有する状態下で測定されたときに、物品の曇り度値は約２０〜６０％の間であり、透過率値は約９４％以下である。
Patent JP-2002511067-A (JP)
IPC: C07K14/575
Filed: 1998-05-27
Abstract: Novel cyclic CRF agonist peptides have the amino acid sequence: (cyclo 30-33)Ac-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-R30-Ala-R32-R33-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 wherein R30 is Glu or Cys; R32 is His, D-His or an equivalent  alpha -amino acid; R33 is Lys, Orn or Cys. The N-terminus may be extended by Ser-Glu-Glu or shortened by up to three more residues. Lys may be substituted for Arg23, and its side chain connected by a lactam bridge to Glu20 to form a bicyclic peptide. Certain disclosed CRF agonists include: (cyclo 30-33)[Ac-Pro4, D-Phe12, Nle21,38, Glu30, D-His32, Lys33]r/hCRF(4-41), (cyclo 30-33)[Ac-Ser7, D-Phe12, Nle21,38, Glu30, Lys33]r/hCRF(7-41), (cyclo 30-33)[Ac-Ser7, D-Phe12, Nle21,38, Glu30, D-His32, Lys33]r/hCRF(7-41), (bicyclo 20-23, 30-33)[Ac-Pro4, D-Phe12, Nle21,38, Lys23,33, Glu30, D-His32]-r/hCRF(4-41), (cyclo 30-33)[Ac-Ser7, D-Phe12, Nle18,21, Glu30, D-Ala32, Lys33] alpha -helical CRF(7-41), and (cyclo 30-33)[Ac-Ser7, D-Phe12, Nle21,38, CML27,40, Glu30, Lys33]r/hCRF(7-41). Labelled agonists such as (cyclo 30-33)[I125Tyr0, D-Phe12, Nle21,38, Glu30, D-His32, Lys33]r/hCRF and (cyclo 30-33)[I125D-Tyr3, D-Phe12, Nle21,38, Glu30, D-His32, Lys33]r/hCRF(3-41) are useful in screening for more potent CRF agonists.
Patent NZ-203593-A (NZ)
Title: Preparation of ortho-methylanilines and quaternary ortho-aminobenzyl ammonium halide salts
Inventor: CHUPP J P
IPC: C07C211/64
Filed: 1983-03-16
Abstract: This invention relates, in one of its aspects, to a process for the preparation of ortho-methyl anilines from ortho-amino benzyl sulfoxides. An ortho-amino benzyl sulfoxide is converted to an ortho-amino benzyl halide by reaction with a nonoxidizing acid halide and is converted to a stable quaternary salt by reaction with a tertiary amine preferably in the presence of an alcohol. The quaternary salt may be cleaved by hydrogenation to form ortho-methyl anilines. Other aspects of the invention relate to novel intermediate quaternary salts and to a process for forming those quaternary salts.
Patent NZ-209712-A (NZ)
Title: Differential temperature apparatus for subjective testing
Inventor: LAUDADIO C
IPC: A61B5/16
Filed: 1984-09-28
Abstract: A differential thermal testing system comprising a first thermal conductive sensing plate (54), a second thermal conductive sensing plate (70), temperature altering means (34) for altering the temperature of the second thermal conductive sensing plate, temperature maintaining means (12, 20, 21 and 22) for maintaining the first thermal conductive plate at a constant first temperature, and temperature detecting means (26, 32) for detecting the temperature differential between the first thermal conductive sensing plate and the second thermal conductive sensing plate. Also described is a method for determining the temperature sensitivity of an area of a subject (not shown) comprising the steps of (a) contacting the area with the first thermal conductive sensing plate (54) having a first temperature, (b) contacting the area with the second thermal conductive sensing plate (70) having a second temperature, and (c) varying the temperature differential between the first thermal conductive sensing plate and the second thermal conductive sensing plate in order to determine the ability of the subject to discriminate between the first temperature and the second temperature.
Patent NZ-211865-A (NZ)
Title: 1,2-benzothiazole-piperidines and pharmaceutical compositions
Inventor: STRUPCZEWSKI J T
IPC: C07D417/04
Filed: 1985-04-22
Abstract: There are described novel anthypertensive 1,2-benzisothiazole piperidines of the formulawhere X is hydrogen, halogen, loweralkoxy, loweralkyl, nitro, amino or trifluoromethyl; and R isR, being loweralkyl, aryl, aralkyl, cycloalkylloweralkyl or a a loweralkyl substituted with an amino, loweralkylamino or diloweralkylamino, and R<sub>2</sub> being hydrogen, loweralkyl or aryl; antihypertensive compositions comprising said compounds or pharmaceutically acceptable acid addition salts thereof; and methods for synthesizing the same.
Patent NZ-214450-A (NZ)
Title: Slat tilting mechanism for venetian blind
Inventor: SPANGENBERG R E
IPC: E06B9/264
Filed: 1985-12-05
Abstract: A venetian blind suitable for mounting in a space between two panes (16,17) of a multiple glazed window assembly (16,17) and comprising upper and lower supporting members (31, 32) between which are mounted the slat supporting means, such as a ladder tape. The supporting member (31,32) carries drive members (47) which are positively driven by a flexible drive element (55), which in turn is driven by an actuating member (58,59) located between the panes (16,17) and an operating element (68) is mounted outside the inner pane (17). The upper and lower supporting members (31,32) are mounted on supporting clips (25) which are held in place by being pushed fitted into upper and lower carriers (14,15) carried by the upper and lower window frame parts (12,13).
Patent NZ-230182-A (NZ)
Title: Portable, controlled release infusion device
Inventor: FASTE ROLF A
IPC: A61M5/145
Filed: 1989-08-02
Abstract: A portable infusion device assembly, having two side-by-side compartments, the first (3) containing the drug or agent (7) to be infused and an osmotic pump (12), and the second (4) containing the driving liquid (17) for the pump (12). The two chambers are separated during storage by a barrier (19,24,27). When the barrier is ruptured, the driving fluid (17) is carried by means of a wick (22) to the osmotic pump (12). The drug (7) is then forced out of the device by the pressure developed by the osmotic pump (12). The assembly is characterized by a very flat profile, and is light, comfortable and inconspicuous in use.
Patent NZ-230827-A (NZ)
Title: Pharmaceutical composition containing an oxapenem-3-carboxylic acid derivative as beta-lactamase inhibitor
Inventor: PFAENDLER HANS-RUDOLF
IPC: C07D503/00
Filed: 1989-09-29
Abstract: The invention relates to the use of 1-oxapenem-3-carboxylic acids of the following structures 
<IMAGE>
 and
 in which R<1> and R<2> have the meaning given in the description, as  beta -lactamase inhibitors and to pharmaceutical compositions which contain the abovementioned 1-oxapenem-3-carboxylic acids and a conventional antibiotic.
Patent NZ-237574-A (NZ)
Title: Pharmaceutically active purine derivatives
Inventor: GLASKY ALVIN J
IPC: A61K47/48
Filed: 1991-03-26
Abstract: Novel bi-functional pharmaceutical compounds, particularly novel 9-substituted hypoxanthines of the general formula:  <IMAGE>  where R is a neurologically active moiety, are described as pharmaceutical agents for treating neuroimmunologic disorders in mammals. Novel methods for the utilization of these compounds are also disclosed. These compounds exhibit uniquely dose-dependent, synergistic biological properties and are particularly useful for treating interrelated physiological systems.
Patent NZ-242169-A (NZ)
Title: Unit dosage drug container - each cavity opening circumscribed with a raised crown or crest
Inventor: BUNIN LEONID
IPC: B65D50/06
Filed: 1992-03-30
Abstract: A child resistant unit dose package for medications comprises a container member (10) having concealed locking means (34), a plurality of cavities (14) along its longitudinal axis for holding medication (15), each cavity closed with a peel-off seal (16), and a cover (20) for the container member that requires two operations to open. In another embodiment, a separate drug container is disclosed which does not include a cover.
Patent NZ-243009-A (NZ)
Title: Substituted 2-acylaminothiazole derivatives, preparation and pharmaceutical compositions
Inventor: BOIGEGRAIN ROBERT
IPC: C07D277/40
Filed: 1992-06-03
Abstract: These compounds correspond to the formula: 
<IMAGE>
 in which R1 represents H or an alkyl, phenylalkyl, aminoalkyl, optionally esterified carboxyalkyl, cyanoalkyl, carbamoylalkyl, hydroxyalkyl or alkoxyalkyl group; RIV represents an optionally substituted cycloalkyl group or an aromatic group such as an optionally substituted phenyl or heterocycle or RIV and RV together represent the group: 
<IMAGE>
 in which u has the value 1 to 3, optionally carrying (np) substituents Xp chosen from halogen, alkyl, alkoxy, nitro and trifluoromethyl, and np have a value from 0 to 3; RV represents a group (CH2)m-X in which m is 0 to 5 and X represents a halogen, a cycloalkyl, an optionally substituted phenyl, a group COOX1; -O-COX1; -SCOX1; (O)q-S-X1 with q = 0, 1 or 2; -O-COOX1; -N-X3-CO-X1 with X3 = H or alkyl; 
<IMAGE>
 with W = O or S and X1 being a C1 to C3 alkyl or an optionally substituted phenyl; a group -COX1X2; -O-CO-NX1X2; or -NX1X2; in which X1 represents an alkyl or phenyl which can be substituted, an alkoxy, or an optionally substituted cyclic or linear amine; a hydroxyl or carboxylic acid group; and Z represents a heterocycle containing one or more heteroatoms chosen from O, S and N, condensed with an aromatic ring which can also contain a heteroatom and which can be substituted, as well as their addition salts.
Patent NZ-248604-A (NZ)
Title: Liquid enteral nutrition product comprising protein and an emulsifier
Inventor: DEWILLE NORMANELLA TORRES
IPC: A23L1/305
Filed: 1993-09-07
Abstract: A liquid enteral nutritional product contains a protein system of, by weight, about 50-90% of a soy protein hydrolysate having a degree of hydrolysis in the range of 14 to 17 and not more than 50% of one or more intact protein sources. The nutritional product may also contain an emulsifier, Iota carrageenan and Kappa carrageenan.
Patent NZ-272524-A (NZ)
Title: Pipe fitting; comprises a double ended hollow spigot having a first end sealably retainable within a pipe fitting and a second end with projecting barbs to engage the pipe
Inventor: CHELCHOWSKI DAVID
IPC: F16L19/08
Filed: 1995-07-07
Abstract: An adaptor 17 for the connection of a polymeric pipe 10 to a filling 13 comprises a double-ended hollow spigot 28 with one end 27 having an outer diameter which is appropriate for a standard fitting 13 and the other end 35 having radially projecting barbs 36 of diameter to engage the inner surface of a pipe 10 with an interfering fit. The fitting 13 includes a fitting nut 23, threadedly engaged with the fitting body, a deformable gripping member 14 with internal barbs 17 which engage the outside of the pipe 10 and also presses the pipe 10 over the external barbs 36 of the inserted spigot 28, and an elastomeric seal 38 which seals against the other end 35 of the spigot 28.
Patent NZ-279729-A (NZ)
Title: Cellular radiotelephone; has dialled number analysis
Inventor: ZICKER ROBERT G
IPC: H04M1/27485
Filed: 1995-02-01
Abstract: A radiotelephone (10) simulates the call origination process performed by land-line telephones. Dial tone is generated (78) in response to an off-hook condition and removed when a first digit (54) is dialed. A timer process (84, 110) and a number analysis process (100) simultaneously evaluate dialed digits to detect the completion of dialing. The number analysis process (100) identifies seven, ten, and eleven digit, and indeterminate length phone number formats (64, 66, 52, 68). The ten digit format is recognized in response to remotely programmed (42) connected NPA codes. For most calls, the number analysis process (100) instantly detects a phone number's final digit (62). In a few cases the timer process (84, 110) detects the final digit through the absence of dialing activity for a predetermined duration. When the final digit (62) is detected, an origination message is transmitted to a cellular network.
Patent NZ-309171-A (NZ)
Title: use of apoptin as an antitumour agent which specifically kills tumour and not normal cells
Inventor: NOTEBORN MATHEUS HUBERTUS MARI
IPC: A61K48/00
Filed: 1996-06-07
Abstract: The use of apoptin for the production of a medicament for anti-tumour therapy comprising a method of eliminating cells of a target cell population whereby the method is mainly by not entirely specific for the cells of the target population whereby apoptin is the cytotoxic agent is claimed. A conjugate for targeted tumour therapy comprising apoptin and a targeting moiety having binding affinity for a molecule associated mainly but not entirely with the surface of a tumour cell is claimed.
Patent NZ-312899-A (NZ)
Title: Peptidyl analogs of a fragment (1-34) of parathyroid hormone
Inventor: DONG ZHENG XIN
IPC: A61K38/00
Filed: 1996-07-03
Abstract: Peptide variants of fragment (1-34) of parathyroid hormone, in which at least one of the amino acid residues at positions 7, 11, 23, 24, 27, 28 and 31 is cyclohexylalanine, or at least one of the amino acid residues at positions 3, 16, 17, 18, 19 and 34 is  alpha -aminoisobutyric acid; or, alternatively, at least the amino acid residue at position 1 is  alpha , beta -diaminopropionic acid, the amino acid residue at position 27 is homoarginine, or the amino acid residue at position 31 is norleucine.
Patent NZ-320276-A (NZ)
Title: Method and preparations for stabilizing biological materials by drying methods without freezing
Inventor: MATTERN MARKUS
IPC: A61K47/26
Filed: 1996-10-24
Abstract: A method of producing dry partially amorphous products comprising macroscopically homogeneous substance mixtures of: a)	proteins, human peptides, glycoproteins, lipoproteins, enzymes, coenzymes, antibodies, antibodies fragments, viruses, viral components, cells and cell components, vaccines, DNA, RNA, PNA, and derivatives thereof and b)	at least one substance of the group comprising: (i) carbohydrate or zwitterion with a polar residue and its derivatives; and (ii) zwitterion with an apolar residue and its derivatives.
Patent NZ-325659-A (NZ)
Title: Transdermal device for the delivery of flurbiprofen
Inventor: EFFING JOCHEM J
IPC: A61K31/00
Filed: 1996-12-16
Abstract: A transdermal drug delivery device involving an acrylate or methacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer, and a therapeutically effective amount of flurbiprofen.
Patent NZ-336362-A (NZ)
Title: Use of a 15-keto-prostaglandin compound as a portal hypertension inhibitor
Inventor: UENO RYUJI
IPC: A61K31/557
Filed: 1998-09-30
Abstract: A 15-keto-prostaglandin compound is used in the manufacture of a medicament for treating portal hypertension by directly affecting the portal vein pressure. The 15-keto-prostaglandin can be a compound of formula I wherein: X and Y are independently hydrogen, halogen, hydroxy, alkyl, hydroxyalkyl or oxo provided that at least one of X and Y is not hydrogen and the 5-membered ring may have a double bond; A is -CH2-OH, -CO-CH2-OH, -COOH or a salt, ester or amide thereof; B is -CH2-CH2-, -CH=CH- or -CºC-; Q1 and Q2 are independently hydrogen, halogen or alkyl; R1 is bivalent, optionally saturated, optionally substituted aliphatic hydrocarbon residue and R2 is optionally saturated, optionally substituted aliphatic hydrocarbon residue.
Patent NZ-337386-A (NZ)
Title: Sustained analgesia achieved with buprenorphine via trans-dermal application
Inventor: REDER ROBERT F
IPC: A61K9/70
Filed: 1998-02-24
Abstract: A method of effectively treating pain in humans is achieved by administering buprenorphine in accordance with first order kinetics over an initial three-day dosing interval, such that a maximum plasma concentration from about 20 pg/ml to about 1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine for at least an additional two-day dosing interval in accordance with substantially zero order kinetics, such that the patients experience analgesia throughout the at least two-day additional dosing interval.
Patent NZ-500170-A (NZ)
Title: An aqueous metal bicarbonate solution and method of use
Inventor: BECKETT RUSSELL JOHN
IPC: A61P29/00
Filed: 1998-03-16
Abstract: A process of preparing a sterile aqueous neutral to mildly alkaline metal bicarbonate solution in a closed or sealed thermodynamic system comprising bicarbonate anions and metal cations.  The process involves reacting a compound selected from metal carbonate, metal carbonate hydroxide, metal oxide, metal hydroxide and any mixture thereof with an effective concentration of a pH adjusting agent to produce the aqueous neutral to mildly alkaline metal bicarbonate solution. The pH-adjusting agent is selected from carbon dioxide, hydrated carbon dioxide, carbonic acid and any mixture thereof and is present in an amount where by the solution has a pH of 7 to 9. The sterile aqueous solution is used to prevent and/or treat inflammatory, viral and/or degenerative diseases that require extracellular or intracellular acidic conditions or extracellular or intracellular proton concentrations at some point in the disease process or disease pathogenesis.
Patent NZ-504110-A (NZ)
Title: Hearing aid comprising an array of microphones
Inventor: BERKHOUT AUGUSTINUS JOHANNES
IPC: H04R25/00
Filed: 1998-10-20
Abstract: Hearing aid for improving the hearing ability  of  the hard  of  hearing,  comprising an array of microphones,  the electrical output signals of which are fed to at  least  one transmission  path belonging to an ear. Means  are  provided for  deriving  two  array  output signals  from  the  output signals  of  the  microphones, the  array  having  two  main sensitivity directions running at an angle with  respect  to one  another  and each of which is associated  to  an  array output  signal. Each array output signal is fed to  its  own transmission  path belonging to one ear of a person  who  is hard of hearing.
Patent NZ-507026-A (NZ)
Title: Method for stabilizing pharmaceutical compositions by special use of an antioxidant
Inventor: KIS GYORGY LAJOS
IPC: A61K31/215
Filed: 1999-03-31
Abstract: Method for stabilizing a pharmaceutical composition  by contacting  said  composition  with  a  polymeric   material comprising an antioxidant.
Patent NZ-508220-A (NZ)
Title: Security element to prevent counterfeiting of value documents
Inventor: LIPPENS PAUL
IPC: G07D7/04
Filed: 1999-04-21
Abstract: A security element is disclosed comprising a magnetic layer and an embossed layer (3), the embossed layer having the form of a diffraction grating device, characterised in that the magnetic layer is a soft-magnetic layer (4) and in that the soft magnetic layer  (4) has, at least partially, the shape of the embossed pattern of the embossed layer (3), whereby the embossed layer (3) affects the magnetic properties of the soft-magnetic layer (4), to a process of manufacture thereof and to the use of such a security element to avoid counterfeiting of value documents.